Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2025-12-25 @ 4:15 PM
NCT ID:
NCT04386057
Group ID:
EG002
Title:
LY3214996 and HCQ Combination
Description:
The research study procedures include screening for eligibility and study treatment. Study treatment will include evaluations, biopsies, and follow up visits. A treatment cycle will be defined as 28 consecutive days. Treatment will be administered on an outpatient basis. Combined dosage per determined Lead-In Cohort
* LY3214996
* HCQ
Hydroxychloroquine Sulfate: HCQ will be administered by mouth twice daily continuously throughout each treatment per 28 day cycle
LY3214996: LY3214996-daily oral dosage per protocol per 28 day cycle
Deaths Number Affected:
18
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
20
Other Number Affected:
16
Other Number At Risk:
20
Study:
NCT04386057
Results Section:
NCT04386057
Adverse Events Module:
NCT04386057